David R. Rubinow, MD, professor and chair of psychiatry at the University of North Carolina School of Medicine and founding director of the UNC Center for Women’s Mood Disorders, has focused extensively on conditions like premenstrual dysphoric disorder.
Sarah Gillespie lived under the shadow of a condition called premenstrual dysphoricdisorder, or PMDD for six long, difficult years.
Artificial intelligence is poised to change the practice of medicine and improve patient outcomes, but challenges remain.
This issue of BioSupply Trends Quarterly explores artificial intelligence, advancements in cardiac care and value-based care.
From personalized medicine and faster diagnostics to predictive analytics and streamlined clinical trials, AI is reshaping healthcare — fast.
Thanks to AI, today's patients are increasingly informed. Here's why clinicians should embrace them as valuable partners in the care process.
Chief Operations Officer Leslie Vaughan on how specialty infusion pharmacy Nufactor, Inc. keeps pace with the changing healthcare landscape by leveraging AI, exploring better plasma production processes and making sure every patient receives the best attention and help getting the immune globulin therapy they need.
When their youngest son Max became ill with measles in 1995, Rüdiger Schoenbohm and his wife, Anke, were naturally concerned. Max was only 6 months old and still too young to have been vaccinated.
George Rust, MD, MPH, joined the faculty of the Florida State University (FSU) College of Medicine in 2016 and serves as medical director for six local county public health department. He is the author of a 2025 measles fact sheet to help address this important public health concern.
Despite growing vaccine skepticism, vaccination continues to be a highly effective public health intervention, saving an estimated four to five million lives per year.
Research continues to push forward, exploring new applications for vaccine technology. From preventing fungal infections to teaching the body to tolerate itself, exciting vaccine developments may soon change the way doctors treat, and even cure, serious disease.
Chief Medical Officer Ross Hoffman, MD, discusses the changing healthcare landscape and offers insight how to best approach its challenges and opportunities.